Quan Jiang

Quan Jiang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
XGXun Gong
Xun Gong
WLWei-Xiang Liu
Wei-Xiang Liu
XTXiao-Po Tang
Xiao-Po Tang
JWJian Wang
Jian Wang
JLJian Liu
Jian Liu
QJQuan Jiang
Quan Jiang
Traditional Chinese medicine (TCM) has been used successfully to treat rheumatoid arthritis (RA). Qingre Huoxue treatment (Qingre Huoxue decoction (QRHXD)/Qingre Huoxue external preparation (QRHXEP)) is a therapeutic scheme of TCM for RA. To date, there have been few studies comparing the efficacy and safety of QRHXD and conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) for the treatment of active RA. This was investigated in a multicenter, double-blind, randomized controlled trial involving 468 Chinese patients with active RA [disease activity score (DAS)-28 > 3.2] treated with QRHXD/QRHXEP (TCM group), methotrexate plus hydroxychloroquine [Western medicine (WM) group], or both [integrative medicine (IM) group]. Patients were followed up for 24 weeks. The primary outcome measure was the change in DAS-28 from baseline to 24 weeks. The secondary outcome measures were treatment response rate according to American College of Rheumatology 20, 50, and 70% improvement criteria (ACR-20/50/70) and the rate of treatment-related adverse events (TRAEs). The trial was registered at ClinicalTrials.gov (NCT02551575). DAS-28 decreased in all three groups after treatment (p < 0.0001); the score was lowest in the TCM group (p < 0.05), while no difference was observed between the WM and IM groups (p > 0.05). At week 24, ACR-20 response was 73.04% with TCM, 80.17% with WM, and 73.95% with IM (based on the full analysis set [FAS], p > 0.05); ACR-50 responses were 40.87, 47.93, and 51.26%, respectively, (FAS, p > 0.05); and ACR-70 responses were 20.87, 22.31, and 25.21%, respectively, (FAS, p > 0.05). Thus, treatment efficacy was similar across groups based on ACR criteria. On the other hand, the rate of TRAEs was significantly lower in the TCM group compared to the other groups (p < 0.05). Thus, QRHXD/QRHXEP was effective in alleviating the symptoms of active RA—albeit to a lesser degree than csDMARDs—with fewer side effects. Importantly, combination with QRHXD enhanced the efficacy of csDMARDs. These results provide evidence that QRHXD can be used as an adjunct to csDMARDs for the management of RA, especially in patients who experience TRAEs with standard drugs.Clinical Trial Registration: ClinicalTrials.gov, identifier NCTNCT025515.

14 June 2022 in Phytomedicine
Verified
Journal Article
Closed access
XGXun Gong
Xun Gong
WLWei-Xiang Liu
Wei-Xiang Liu
DLDa Li
Da Li
QPQiu-Wei Peng
Qiu-Wei Peng
CXCong-Min Xia
Cong-Min Xia
QJQuan Jiang
Quan Jiang

4 April 2021 in Rheumatology and Therapy
Verified
Journal Article
Open access
PDF file
JJJuan Jiao
Juan Jiao
ZCZengyu Cheng
Zengyu Cheng
WWWen Wang
Wen Wang
YZYayun Zhao
Yayun Zhao
QJQuan Jiang
Quan Jiang
Objective The aim of this study is to characterize the demographics, fibromyalgia-related symptom severity and quality of life (QOL) among Chinese fibromyalgia patients. Methods A total of 124 patients who met the ACR 1990 criteria were recruited. Each subject completed a packet of questionnaires for collecting data on the demographics, medical history and severity of six major symptoms of fibromyalgia (i.e., pain, fatigue, sleep quality, depression, stress and QOL). Results The majority of the study subjects were women (86.3%), were married (78.2%) and had a mean age of 49.4 years and a median symptom duration of 24 months. Compared to their female counterparts, male patients were younger, were more likely to be employed, had a higher income and were more likely to be current smokers and alcohol drinkers (all p ≦ 0.027). Most patients experienced moderate to severe pain (69.4%), severe fatigue (70.2%) and moderate to severe depression (53.3%). A small percentage (19.4%) of the patients had very poor quality of sleep, and over one third (37.1%) suffered from moderate to severe stress. Less than one third (27.5%) patients’ health status was moderately or highly impacted by fibromyalgia. The mental health of men was affected significantly more than that of women, with lower SF-36 scores in the SF-36 mental component summary (p = 0.043) and role emotional (p = 0.006). Conclusion This study has revealed that Chinese fibromyalgia patients might share similar demographics but milder fibromyalgia-related symptoms and better mental QOL compared to patients of other races and ethnic groups. Some differences between male and female patients were found, too. Further cross-sectional studies with a larger sample size and nationwide study sites are needed to replicate those clinical findings.

10 July 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
CYChuanhui Yao
Chuanhui Yao
XGXun Gong
Xun Gong
BSBiyue Shang
Biyue Shang
DDDan Dou
Dan Dou
WLWeixiang Liu
Weixiang Liu
QJQuan Jiang
Quan Jiang
Interstitial lung disease (ILD) is a common and severe comorbidity of rheumatoid arthritis (RA), yet reliable diagnostic biomarkers remain lacking. Alveolar type II (ATII) cells are widely recognized to play a key role in the pathogenesis of ILD. This study first aimed to screen and validate potential autoantigens involved in RA-ILD using ATII cells. Sera from multiple patient groups were subjected to immunoprecipitation with ATII cells and analyzed for candidate autoantigens related to RA-ILD through proteomic methods. Antibody concentrations in the sera were subsequently measured using protein chips and ELISA. Expression levels of target antigens in the lung tissues of collagen-induced arthritis-bleomycin (CIA-BLM) mice were evaluated via immunohistochemistry, while their expression in ATII-BLM cells was assessed using indirect immunofluorescence. The diagnostic value of these antibodies was further examined by ROC curve analysis. Preliminary studies also explored the cellular mechanisms involved. We identified exosome component 4 (EXOSC4) as a potential autoantigen in RA-ILD, with significantly higher levels of EXOSC4 antibodies found in the sera of RA-ILD patients. Moreover, EXOSC4 expression was elevated in the lung tissues of CIA-BLM mice and in ATII-BLM cells. Clinical assessments showed that the area under the curve (AUC) for EXOSC4 antibody in diagnosing RA-ILD was 0.809, increasing to 0.890 (95% CI:0.812–0.967) when combined with other clinical indicators. Notably, EXOSC4, Wnt 3a, and β-catenin expression were significantly upregulated in ATII-BLM cells as compared to ATII cells. Additionally, we found a significant interaction between naïve CD4 + T cells and ATII cells within the Wnt/β-catenin signaling pathway, suggesting a possible mechanistic role of EXOSC4 in RA-ILD pathogenesis. We identified EXOSC4 as a novel autoantigen associated with RA-ILD, which may assist in its clinical diagnosis.

15 February 2025 in The American Journal of the Medical Sciences
Verified
Journal Article
Open access
ZLZixia Liu
Zixia Liu
XMXieli Ma
Xieli Ma
TCTian Chang
Tian Chang
CYChuanhui Yao
Chuanhui Yao
MSMengge Song
Mengge Song
QJQuan Jiang
Quan Jiang
Uric acid (UA) has been associated with an increased incidence of psoriasis (PsO) and psoriatic arthritis (PsA). Clinical evidence shows that patients with PsO often have elevated serum UA levels, contributing to HUA and gout. This study investigated the bidirectional relationships among hyperuricemia (HUA), gout, PsO, and PsA through a systematic review and meta-analysis. To evaluate the associations between PsO, PsA, and the risks of HUA and gout. PubMed, Embase, CNKI, and Wanfang databases were searched for relevant literature published from databases inception until February 2024.Quality was assessed using the Newcastle-Ottawa Scale (NOS). A total of 8 studies were included. Eligible studies included case-control, cohort, and cross-sectional studies.The meta-analysis showed that patients with PsO had a 2.56-fold higher risk of HUA [OR = 2.56, 95% CI (1.82-3.59)] while PsA patients had a 3.56-fold higher risk of HUA [OR = 3.56, 95% CI (2.04-6.20)]. The risk of gout was 4.95 times higher in PsA [OR = 4.95, 95% CI (2.72-9.01)] and 1.95 times higher in PsO [OR = 1.95, 95% CI (1.02-3.75)]. This study demonstrated an bidirectional relationship between psoriasis, psoriatic arthritis and gout or hyperuricemia, highlighting the need for clinicians to consider these conditions in managing the studied diseases.

30 July 2023 in Oral Diseases
Verified
Journal Article
Open access
RLRuihua Liu
Ruihua Liu
YZYi Zhang
Yi Zhang
KLKesong Li
Kesong Li
HXHaodong Xu
Haodong Xu
ZCZengyu Cheng
Zengyu Cheng
QJQuan Jiang
Quan Jiang
Aim: The aim of the study was to observe the effect of acupuncture on regulating interleukin (IL)‐17, tumor necrosis factor (TNF)‐ɑ, and aquaporins (AQPs) in Sjögren's syndrome (SS) on patients and on non‐obese diabetic (NOD) models.Methods: Levels of anti‐AQP 1, 5, 8, and 9 antibodies, IL‐17, and TNF‐ɑ in the serum of SS patients were compared prior and following 20 acupuncture treatment visits during 8 weeks. While in murine model, five groups were divided to receive interventions for 4 weeks, including control, model, acupuncture, isoflurane, and hydroxychloroquine. The submaxillofacial gland index, histology, immunohistochemistry of AQP1, 5, salivary flow, together with IL‐17, and TNF‐ɑ expression in peripheral blood were compared among the groups.Results: Acupuncture reduced IL‐17, TNF‐ɑ, and immunoglobin A levels, and numeric analog scale of dryness in 14 patients with SS (p < 0.05). The salivary flow was increased, and the water intake decreased in NOD mice receiving acupuncture treatments. IL‐17 and TNF‐ɑ levels in peripheral serum were down‐regulated (p < 0.05) and AQP1, 5 expression in the submandibular glands up‐regulated in mice.Conclusion: The effect on relieving xerostomia with acupuncture may be achieved by up‐regulating the expression of AQP1. AQP5, down‐regulating levels of IL‐17 and TNF‐ɑ, and a decrease in inflammation of glands.